Szerző: admin | júl 23, 2024 | Blog
Cell-free DNA Fragmentomics: A Promising Predictor of Cancer Cell-free DNA (cfDNA) represents extracellular DNA secreted into the bloodstream by cells undergoing programmed cell death. Notably, a portion of this cfDNA originates from cancer cells, termed circulating...
Szerző: admin | ápr 18, 2024 | Blog
New developments in the field of circulating tumor cells (2024) Circulating Tumor Cells: From Basic to Translational Research – Cortés-Hernández et al Although the potential of circulating tumor cells (CTCs) as prognostic agents is undisputed, up until recently,...
Szerző: admin | dec 21, 2023 | Blog
Singlera technologies 5: Panseer – detecting pan-cancer signatures years before conventional diagnosis Non-invasive early detection of cancer four years before conventional diagnosis using a blood test – Chen et al. In the last blog of the year and the concluding...
Szerző: admin | nov 30, 2023 | Blog
Singlera Technologies 4: Catching Pancreatic Cancer early with intricate methylation markers Noninvasive detection of pancreatic ductal adenocarcinoma using the methylation signature of circulating tumour DNA. – Wu et al. Highlights One significant hurdle in...
Szerző: admin | okt 31, 2023 | Blog
Singlera technologies 3: Methylation signatures for hepatocellular carcinoma detection Identification of DNA methylation signatures for hepatocellular carcinoma detection and microvascular invasion prediction. – Hao et al. Highlights Hepatocellular carcinoma (HCC) is...
Szerző: admin | szept 28, 2023 | Blog
Singlera technologies 2: Early detection of residual molecular disease in colorectal cancer through circulating tumor DNA methylation Colorectal cancer (CRC), the second most common cause of cancer-related death, has a 5-year survival rate as low as 60%. This is...
